跳至主要内容
临床试验/CTRI/2022/10/046368
CTRI/2022/10/046368已完成2/3 期

“A Clinical study to evaluate the safety and efficacy of Chawayanshakti Powder as physical health and immunity boosterâ€.

KAG Industries, Nahan H.P1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2022年10月17日最近更新:

试验速览

阶段
2/3 期
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
Increase in hemoglobin and IgG and IgM

研究概览

简要总结

Chawayan Shakti is a polyherbal ayurvedic drug which is intended to be used as a general health tonic and immunobooster. The contents of the drug are well known for their Rasayana or antioxidant properties as well as immunity boosting effects. The present study is to validate the efficacy of this drug and also to evaluate its safety and tolerability in general population.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • healthy individuals in the age group of 18-65 years willing for trial and able to come for follow up.

排除标准

  • individuals who are unwilling for trial or below 18 and above 65 years of age or having any concomitant illness requiring medical intervention.
  • individuals allergic to milk or components of Chawayan shakti powder.

结局指标

主要结局

Increase in hemoglobin and IgG and IgM

时间窗: at baseline, 15 days and 30 days

次要结局

  • Clinical safety and tolerability of Chawayan Shakti powder as seen by its effecs on renal function and Liver enzymes.(15 days and 30 days)

研究者

发起方
KAG Industries, Nahan H.P
申办方类型
Other [Food Manufacturer]

研究点 (1)

Loading locations...

相似试验